NORTHBROOK, Ill., April 25, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by ...

NeoCon veteran Clarus Glassboards showcased its most cohesive, elevated, and visually stunning showroom to date.

What Happened? A number of stocks jumped in the afternoon session after strong retail sales data for May revealed that consumer spending was robust despite inflation and high gas prices. According to ...

(RTTNews) - Clarus Corp. (CLAR) said it is not aware of any new material developments or pending announcements concerning its business operations that may be contributing to the recent volatile market ...

Clarus Therapeutics Holdings Inc CRXT shares traded lower by 32.24% to $0.14 during Monday's trading session after the company announced it has received a non-compliance letter from Nasdaq. The shares ...

Forget Stage Manager, forget Live Captions — from now on macOS Ventura will be famous for bringing back Clarus the Dogcow to its rightful place. The dogcow is not Susan Kare's finest hour, except that ...

Clarus Therapeutics will immediately reduce its headcount by 40% in an effort to stay afloat and avoid filing for bankruptcy protection. The Northbrook company also announced today that Chief ...

Clarus Corp. faces a challenging year, but its strong brands, large cash balance, and no debt position it for future growth. Clarus's enterprise value is under $100 million, but its brands could ...

View Clarus Corporation CLAR stock quote prices, financial information, real-time forecasts, and company news from CNN.